M. Kaneuchi

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
M Kaneuchi, M. Kaneuchi, Masanori Kaneuchi, Masanori Kaneuchi*
Publication record
117 papers · 4,143 citations · H-index 36

PAPERS

Impact of adjuvant chemotherapy on the overall survival of patients with resectable bulky small cell neuroendocrine cervical cancer: a JSGO-JSOG joint study
20228 citationsauthor #8
Significance of histology and nodal status on the survival of women with early-stage cervical cancer: validation of the 2018 FIGO cervical cancer staging system
20222 citationsauthor #10
Sentinel node navigation surgery in cervical cancer: a systematic review and metaanalysis
202225 citationsauthor #10
Comparison of treatment outcomes of surgery and radiotherapy, including concurrent chemoradiotherapy for stage Ib2-IIb cervical adenocarcinoma patients: a retrospective study
20214 citationsauthor #7
Nerve-Sparing Radical Hysterectomy Using the Okabayashi–Kobayashi Method
20216 citationsauthor #2
Clinicopathological characteristics and prognostic factors of ovarian granulosa cell tumors: A JSGO-JSOG joint study.
202115 citationsauthor #5
The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer
202154 citationsauthor #6
A retrospective study for investigating the outcomes of endometrial cancer treated with radiotherapy
20212 citationsauthor #7
Oncological Outcomes After Okabayashi-Kobayashi Radical Hysterectomy for Early and Locally Advanced Cervical Cancer
202022 citationsauthor #4
Nerve-sparing radical hysterectomy in the precision surgery for cervical cancer
202032 citationsauthor #4
Intraoperative capsule rupture, postoperative chemotherapy, and survival of women with stage I epithelial ovarian cancer: A JSOG-JSGO joint study
20201 citationsauthor #7
Tailored radical hysterectomy for locally advanced cervical cancer
20204 citationsauthor #2
Coincidental detection of diffuse large B-cell lymphoma in the inner inguinal lymph node of a woman undergoing laparoscopic pelvic lymph node dissection for uterine endometrial cancer
20200 citationsauthor #5
Impact of lymphadenectomy on the treatment of endometrial cancer using data from the JSOG cancer registry
20208 citationsauthor #7
Proposal of a Two-Tier System in Grouping Adenocarcinoma of the Uterine Cervix
20209 citationsauthor #8
Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: A JSGO-JSOG joint study
20200 citationsauthor #7
Paracervical and paravaginal tissue dissection in the Okabayashi–Kobayashi radical hysterectomy and nerve-sparing technique
20201 citationsauthor #2
EP398 Nerve-sparing radical hysterectomy: a standardized method for precision surgery and local control in cervical cancer
20190 citationsauthor #6
Trends and characteristics of epithelial ovarian cancer in Japan: JSGO-JSOG joint study
20190 citationsauthor #7
Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms
201990 citationsauthor #6
Intraoperative Capsule Rupture, Postoperative Chemotherapy, and Survival of Women With Stage I Epithelial Ovarian Cancer
201954 citationsauthor #7
Survival outcome and perioperative complication related to neoadjuvant chemotherapy with carboplatin and paclitaxel for advanced ovarian cancer: A systematic review and meta-analysis.
201945 citationsauthor #7
Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer
2018113 citationsauthor #5
Quality indicators for cervical cancer care in Japan
201817 citationsauthor #5
Association between ovarian endometrioma and ovarian reserve.
201837 citationsauthor #6
Expression levels of C19MC and C14MC microRNAs in complete hydatidiform moles and ovarian mature cystic teratomas
20181 citationsauthor #6
Instructions for use Title Impact of FDG PET in optimizing patient selection for cytoreductive surgery in recurrent ovariancancer
20170 citationsauthor #3
Management of Ovarian Cancer in the Elderly Population
20170 citationsauthor #1
Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer
201756 citationsauthor #15
Current status of tertiary debulking surgery and prognosis after secondary debulking surgery for recurrent Müllerian epithelial cancer in Japan: a retrospective analysis of 164 patients (KCOG-G1402)
20174 citationsauthor #20
Carbon dioxide angiography and arterial embolization could successfully control postpartum uterine hemorrhage for the patient with hypersensitivity to iodine compound
20171 citationsauthor #2
ISP-20-8 Circulating levels of C19MC-cluster microRNAs in pregnant women with severe preeclampsia(Group 20 PIH,International Session Poster)
20160 citationsauthor #10
A significant association between rs8067378 at 17q12 and invasive cervical cancer originally identified by a genome-wide association study in Han Chinese is replicated in a Japanese population
201615 citationsauthor #4
Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer
2016106 citationsauthor #9
ISP-26-1 Normal ranges of plasma concentrations of pregnancy-associated microRNAs during pregnancy(Group 26 Maternal Complication 2,International Session Poster)
20160 citationsauthor #8
ISP-33-4 Fertility preservation in three AYA women with myelodysplastic syndrome(Group 33 Fertility Preservation,International Session Poster)
20160 citationsauthor #6
[Diabetes mellitus and endometrial cancer].
20160 citationsauthor #1
Pregnancy-associated microRNAs in plasma as potential molecular markers of ectopic pregnancy.
201536 citationsauthor #6
Circulating chromosome 19 miRNA cluster microRNAs in pregnant women with severe pre‐eclampsia
201551 citationsauthor #9
Circulating levels of maternal plasma cell‐free miR‐21 are associated with maternal body mass index and neonatal birth weight
20155 citationsauthor #6
Effect of labor on plasma concentrations and postpartum clearance of cell‐free, pregnancy‐associated, placenta‐specific microRNAs
201516 citationsauthor #8
Predominantly placenta‐expressed mRNAs in maternal plasma as predictive markers for twin–twin transfusion syndrome
20148 citationsauthor #8
MicroRNA‐106b modulates epithelial–mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines
201489 citationsauthor #2
Impact of FDG PET in optimizing patient selection for cytoreductive surgery in recurrent ovarian cancer
201436 citationsauthor #3
Prospective risk of stillbirth in women with placental mesenchymal dysplasia
201416 citationsauthor #5
Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer.
201442 citationsauthor #2
Genital infection caused by Entamoeba histolytica confirmed by polymerase chain reaction analyses
20141 citationsauthor #2
Identification of endometrioid endometrial carcinoma-associated microRNAs in tissue and plasma.
201495 citationsauthor #5
Single human papillomavirus 16 or 52 infection and later cytological findings in Japanese women with NILM or ASC-US
20142 citationsauthor #11
Gestational weight gain according to number of fetuses in Japanese women
201412 citationsauthor #7
ISO-1-1 miR-31 is an endometrial cancer oncogene that targets LATS2 and suppresses hippo tumor suppressor pathway(Group 1 Oncology 1,IS Award Candidate,International Session)
20130 citationsauthor #9
Multivariate prognostic analysis of adenocarcinoma of the uterine cervix treated with radical hysterectomy and systematic lymphadenectomy
201333 citationsauthor #8
ISP-6-5 Preventive intervention for lower-limb lymphedema at early postoperative period in gynecological cancer(Group 6 Women's Health 3,IS Poster,International Session)
20130 citationsauthor #9
Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women
201326 citationsauthor #8
Coagulation/Fibrinolysis and laboratory characteristics of pregnant women with severely depressed antithrombin activity
201315 citationsauthor #9
ISP-15-4 New Biomarkers for Lymph Node Metastasis in Patients with Endometrial Cancer using Exon-expression Microarray(Group 15 Oncology 6,IS Poster,International Session)
20130 citationsauthor #3
Emerging Therapeutic Biomarkers in Endometrial Cancer
2013179 citationsauthor #2
[Diabetes mellitus and women's cancer].
20120 citationsauthor #1
Total Abdominal Hysterectomy : to Prevent Ureteral Injury
20120 citationsauthor #1
New revised FIGO 2008 staging system for endometrial cancer produces better discrimination in survival compared with the 1988 staging system
201226 citationsauthor #13
Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b–ZEB1 axis
2012265 citationsauthor #4
A validation study of the new revised FIGO staging system to estimate prognosis for patients with stage IIIC endometrial cancer.
201122 citationsauthor #9
Exploration of biomarkers for lymph node metastasis in patients with endometrial cancer using exon-expression microarray.
20112 citationsauthor #8
MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1
2011230 citationsauthor #2
Multivariate survival analysis of the patients with recurrent endometrial cancer
201158 citationsauthor #10
A Retrospective Analysis of Postoperative Complications With or Without Para-aortic Lymphadenectomy in Endometrial Cancer
201165 citationsauthor #9
Initial failure site according to primary treatment with or without para-aortic lymphadenectomy in endometrial cancer.
201130 citationsauthor #9
Incidence of metastasis in circumflex iliac nodes distal to the external iliac nodes in intermediate- and high-risk endometrial cancer.
201113 citationsauthor #9
Risk factors for lower-limb lymphedema after surgery for cervical cancer
2011100 citationsauthor #4
Does dietary estrogen intake from meat relate to the incidence of hormone-dependent cancers?
20105 citationsauthor #5
Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis.
2010704 citationsauthor #3
Para-aortic lymphadenectomy in endometrial cancer. Authors' reply
20100 citationsauthor #4
Risk Factors for Persistent Low Bladder Compliance After Radical Hysterectomy
201036 citationsauthor #7
ORIGINAL ARTICLE: A High Dose of Intravenous Immunoglobulin Increases CD94 Expression on Natural Killer Cells in Women with Recurrent Spontaneous Abortion
200925 citationsauthor #4
Experience of pelvic peritonectomy in patients with persistent pelvic pain
20080 citationsauthor #5
Clinical study of laparoscopic para-aortic lymphadenectomy using a Cavitron ultrasonic surgical aspirator
20080 citationsauthor #2
Incidence of pulmonary embolism in patients undergoing laparoscopic surgery for gynecologic malignancies
20080 citationsauthor #5
Retrospective analysis of two modes of lymphadenectomy (para-aortic + pelvic vs. pelvic alone) with regard to survival in endometrial cancer: A comparative study of two gynecologic units
20072 citationsauthor #5
High-grade broad ligament cancer of müllerian origin: immunohistochemical analysis of a case and review of the literature
200619 citationsauthor #3
0314: Preoperative Serum Ca125 Level As a Predictor of 3-Year Survival in Ovarian Clear Cell Adenocarcinoma
20060 citationsauthor #2
Catechol-O-methyltransferase Gene Polymorphisms in Benign Prostatic Hyperplasia and Sporadic Prostate Cancer
200639 citationsauthor #12
WT1 and WT1‐AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma
200566 citationsauthor #1
Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer.
200526 citationsauthor #9
Functional Loss of the g-Catenin Gene through Epigenetic and Genetic Pathways in Human Prostate Cancer
20056 citationsauthor #9
Functional Loss of the γ-Catenin Gene through Epigenetic and Genetic Pathways in Human Prostate Cancer
200552 citationsauthor #9
422: Polymorphisms of Cytochrome P450 1B1 are Risk Factors for Prostate Cancer
20041 citationsauthor #5
Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer.
200461 citationsauthor #1
CYP1B1 gene in endometrial cancer.
200345 citationsauthor #2
Endometrial Cancer Are Selectively Inactivated by CpG Hypermethylation in Gene Catechol-O-methyltransferase Multiple Promoters of Updated
20032 citationsauthor #2
Estrogen receptor alpha polymorphisms and renal cell carcinoma--a possible risk.
200347 citationsauthor #3
Retraction: CYP1B1 Gene Polymorphisms Have Higher Risk for Endometrial Cancer, and Positive Correlations with Estrogen Receptor α and Estrogen Receptor β Expressions.
20039 citationsauthor #3
Cytological features of cervical smears in serous adenocarcinoma of the endometrium.
200312 citationsauthor #8
CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor alpha and estrogen receptor beta expressions.
200349 citationsauthor #3
The Human T-Cell Factor-4 Gene Splicing Isoforms , Wnt Signal Pathway , and Apoptosis in Renal Cell Carcinoma 1
20030 citationsauthor #11
The polyglycine and polyglutamine repeats in the androgen receptor gene in Japanese and Caucasian populations.
200339 citationsauthor #2
Alleles of polymorphic sites that correspond to hyperactive variants of CYP1B1 protein are significantly less frequent in Japanese as compared to American and German populations
200319 citationsauthor #3
DNA mismatch repair genes in renal cell carcinoma.
200337 citationsauthor #4
Hypermethylation can selectively silence multiple promoters of steroid receptors in cancers.
200366 citationsauthor #2
Resveratrol suppresses growth of Ishikawa cells through down-regulation of EGF.
200347 citationsauthor #1
The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
200383 citationsauthor #11

TIMELINE

1992 0 citations

1999 99 citations

2000 47 citations

2001 4 citations

2002 162 citations

2003 590 citations

2004 62 citations

2005 150 citations

2006 58 citations

2007 2 citations

2008 0 citations

2009 25 citations

2010 745 citations

2011 520 citations

2012 291 citations

2013 253 citations

2014 301 citations

2015 108 citations

2016 121 citations

2017 61 citations

2018 168 citations

2019 189 citations

2020 77 citations

2021 81 citations

2022 35 citations

M. Kaneuchi

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT